The natriuretic effect of GLP-1RAs may also be partially attributed to a reduction of the activity of the reninangiotensinaldosterone system, as in clinical studies, GLP-1 and GLP-1RAs have been found to lower circulating angiotensin II levels by approximately 20% [24, 25]
The ingredients are lightly dosed, the delivery method is unproven, and the cited research doesnt back up the claims made, especially when it comes to GLP-1-related effects
If the absence of effect is due to the choline form used, or the age of the individual is not known (172)
For a research context, retatrutide is the logical choice when the objective is maximal receptor coverage, because it already contains the GLP-1 activity that Ozempic provides plus the GIP and glucagon arms
This is an incidental benefit rather than a primary use case
You can always escalate, but you cannot reverse a week of severe nausea